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ABSTRACT
Introduction It has been suggested that interventions 
focusing on individual behaviour change, such as 
behavioural weight management interventions, may 
exacerbate health inequalities. These intervention- 
generated inequalities may occur at different stages, 
including intervention uptake, adherence and 
effectiveness. We will synthesise evidence on how 
different measures of inequality moderate the uptake, 
adherence and effectiveness of behavioural weight 
management interventions in adults.
Methods and analysis We will update a previous 
systematic literature review from the United States 
Preventive Services Taskforce to identify trials of 
behavioural weight management interventions in adults 
aged 18 years and over that were, or could feasibly be, 
conducted in or recruited from primary care. Medline, 
Cochrane database (CENTRAL) and PsycINFO will be 
searched. Only randomised controlled trials (RCTs) and 
cluster- RCTs will be included. Two investigators will 
independently screen articles for eligibility and conduct 
risk of bias assessment. We will curate publication 
families for eligible trials. The PROGRESS- Plus acronym 
(place of residence, race/ethnicity, occupation, gender, 
religion, education, socioeconomic status, social capital, 
plus other discriminating factors) will be used to consider 
a comprehensive range of health inequalities. Data on 
trial uptake, intervention adherence, weight change and 
PROGRESS- Plus- related data will be extracted. Data will 
be synthesised narratively. We will present a Harvest plot 
for each PROGRESS- Plus criterion and whether each trial 
found a negative, positive or no health inequality gradient. 
We will also identify potential sources of unpublished 
original research data on these factors which can be 
synthesised through a future individual participant data 
meta- analysis.
Ethics and dissemination Ethical approval is not 
required as no primary data are being collected. The 
completed systematic review will be disseminated in a 
peer- reviewed journal, at conferences, and contribute to 
the lead author’s PhD thesis. Authors of trials included 
in the completed systematic review may be invited to 
collaborate on a future individual participant data meta- 
analysis.
PROSPERO registration number CRD42020173242.
INTRODUCTION
Rationale
Overweight and obesity are associated 
with an increased risk of a number of non- 
communicable diseases such as type 2 
diabetes, cardiovascular disease and some 
cancers (including post- menopausal breast, 
bowel and oesophageal).1 2 People living 
with overweight and obesity have greater all- 
cause mortality compared with those within 
a healthy weight range.3 There are known 
health inequalities by place of residence, 
ethnicity, occupation, sex, religion, educa-
tion, socioeconomic status (SES), social 
capital and other factors such as disability and 
sexual orientation (PROGRESS- Plus).4 Obser-
vational research suggests that inequalities in 
overweight and obesity exist across several of 
these criteria, such as SES and education,5–10 
although these measures are generally more 
predictive of obesity in women than men.9 11
Strengths and limitations of this study
 ► A description of existing data that relate to inequal-
ities in behavioural weight management trials, and 
where they occur will be provided, enabling future 
meta- analysis of individual participant data.
 ► A comprehensive search strategy, which has previ-
ously been validated in the literature, will be used to 
identify relevant trials.
 ► Where data permit, subgroup analysis of association 
or interaction between the PROGRESS- Plus criteria 
(place of residence, race/ethnicity, occupation, gen-
der, religion, education, socioeconomic status, social 
capital, plus other discriminating factors) and trial 
uptake, adherence and effectiveness will be pre-
sented in a Harvest plot.
 ► Only randomised controlled trials (RCTs) and cluster 
RCTs will be included.
 ► There is likely heterogeneity in measures of 
PROGRESS- Plus criteria used, as well as limit-
ed publication of data, which is likely to prevent a 
meta- analysis being conducted.
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Both ‘upstream’ and ‘downstream’ interventions are 
needed to reduce the prevalence of obesity through 
primary prevention and treatment for those living 
with overweight and obesity. There is suggestion that 
‘upstream’ interventions - that is, those aimed at a 
population- level and requiring little personal agency - 
are the most equitable,12 and may reduce inequalities in 
overweight and obesity prevalence. On the other hand, 
‘downstream’ interventions, targeted at high- risk groups 
and individuals (such as those who already have over-
weight or obesity) and requiring high personal agency, 
are likely to be inequitable. Inequitable interventions may 
exacerbate health inequalities if they are less effective at 
reducing overweight and obesity prevalence in disadvan-
taged groups. Behavioural weight management inter-
ventions, such as those provided in or referred to from 
primary care, require a high level of personal agency as 
participants are required to attend and be engaged with 
an intervention for it to be effective.13 Hence, behavioural 
weight management interventions may inadvertently 
exacerbate health inequalities.
The overall effectiveness of behavioural weight 
management interventions was considered in a systematic 
review and meta- analysis for the United States Preventive 
Services Task Force (USPSTF).14 The review considered 
behavioural weight loss and behavioural weight loss main-
tenance interventions, as well as pharmacological weight 
loss and weight loss maintenance interventions. It found 
that primary care- relevant behavioural weight loss inter-
ventions were associated with greater mean weight loss 
at 12–18 months when compared with a control, while 
behavioural weight loss maintenance interventions are 
effective at preventing weight regain. Moderation of 
effectiveness by any of the PROGRESS- Plus criteria was 
not considered, although narrative comment was made 
about the reporting of ethnicity and SES. Unless a specific 
ethnicity was targeted in the intervention, the authors 
found that ethnicity and SES were not well reported. 
Where ethnicity and SES were reported, most participants 
were white and of mid- to- high SES. Income, employment 
and/or occupation were the most frequently reported 
measures of SES.
We identified one previous systematic review from 
Hillier- Brown et al that considered the effectiveness 
of individual- level, community- level and societal- level 
interventions at reducing socioeconomic inequalities 
in obesity.11 The individual (n=5) and community inter-
ventions (n=12) included in the systematic review were 
similar to the behavioural interventions included in the 
USPSTF review. They defined individual- level interven-
tions as being conducted in a healthcare, research or 
home setting and delivered one- to- one. Community- 
level interventions were defined as being delivered to a 
group and taking place in community settings such as 
in community or sports centres. The review found that, 
for individual- level interventions, evidence for reducing 
inequalities in obesity among adults was only found in 
tailored weight loss programmes targeted at low- income 
groups, particularly those in primary care settings, rather 
than for ‘universal’ interventions. Evidence was gener-
ally only for short- term outcomes (up to 9 months). 
Community- level interventions showed positive effects up 
to 3 months, although there was no evidence for longer- 
term positive effects. Meanwhile, there was little evidence 
for the impact of societal- level (‘upstream’) interventions 
on inequalities in obesity among adults, and the included 
evidence was of low quality.
There are some limitations of the Hillier- Brown et al 
review. A meta- analysis was not conducted, due to hetero-
geneity of the included studies. While a highly sensi-
tive search strategy was used, only literature works that 
reported differential effects by a measure of SES were 
included. This meant that interventions which may have 
collected data on SES, but had not included it in anal-
yses reported in a published paper, would have been 
excluded. The authors highlighted this may explain 
why mostly interventions taking a targeted approach to 
reducing SES inequalities were included; only a minority 
of studies examined intervention effects across the SES 
gradient. They also suggest that this targeted approach 
‘has limitations as even when interventions are effective 
among low- income groups they are only able to reduce 
the health inequalities gap, they have little effect on the 
wider social gradient’. Literature published since Hillier- 
Brown et al has considered the effect of universal inter-
ventions on health inequalities among adults.15 16
The Hillier- Brown et al review only considered inequal-
ities in intervention effectiveness. Intervention- generated 
inequalities may occur at several stages.12 First, in inter-
vention uptake.17 This may occur because of differing 
levels of weight loss service provision by geography or 
because some groups are less likely to take up the offer 
of an intervention. Research using the Clinical Practice 
Research Datalink in the UK found that certain groups, 
such as those in deprivation, may be more likely to access 
weight management interventions,18 suggesting that such 
interventions may have a positive effect on health inequal-
ities. Second, inequalities may occur in the adherence to 
an intervention.19 Adherence to an intervention may be 
affected by certain barriers such as access to transport,20 
insufficient time or other social circumstances. Third, 
there may be inequalities in outcome—those of a certain 
socioeconomic position or ethnicity may have similar 
uptake and adherence to an intervention, but there may 
be other factors that mean that the intervention is less 
effective for them than for other people. This may be 
because the intervention is not culturally or contextually 
tailored appropriately.
In the current systematic review, we will synthesise liter-
ature on inequalities across the uptake, adherence and 
effectiveness of behavioural weight management interven-
tions. The lack of reporting or analysis by measures associ-
ated with the PROGRESS- Plus criteria identified in both 
the USPSTF and Hillier Brown et al’s systematic reviews 
suggest that it is not possible to fully explore inequalities 
in the effectiveness using aggregated data from published 
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literature alone. This lack of reporting may have occurred 
because individual trials may not be sufficiently powered 
to detect an interaction between moderators such as SES 
and the outcome; they are likely just to be sufficiently 
powered to detect the main, overall effect. This systematic 
review will also identify trials with unpublished data on 
measures of inequality across the PROGRESS- Plus criteria 
in order to conduct a future individual participant data 
meta- analysis.
Objectives
The overall aim is to identify and describe inequalities in 
the update, adherence and effectiveness of behavioural 
weight management interventions. We will meet this 
aim through the following objectives: (1) to synthesise 
published literature on how inequalities across different 
PROGRESS- Plus criteria moderate the uptake, adher-
ence and effectiveness of behavioural weight manage-
ment interventions; and (2) to identify published trials 
that have unpublished data on how inequalities across 
different PROGRESS- Plus criteria moderate the uptake, 
adherence and effectiveness of behavioural weight 
management interventions.
METHODS
This protocol was written in accordance with the Preferred 
Reporting Items for Systematic Review and Meta- Analysis 
Protocols (PRISMA- P) reporting guidelines for systematic 
review protocols (online supplemental file A).21
Study design
We will conduct a systematic review of published 
randomised controlled trials (RCTs) of behavioural 
weight management interventions (which includes 
interventions for both behavioural weight loss and 
behavioural weight loss maintenance). PROGRESS- Plus 
criteria- related measures and data (outlined in table 1) 
will be extracted and evidence regarding their impact on 
uptake, adherence and effectiveness will be synthesised. 
Furthermore, we will identify where data relating to the 
PROGRESS- Plus criteria have been collected and their 
relationship with uptake, adherence and effectiveness 
not analysed, to facilitate future individual participant 
data meta- analysis.
Initially, relevant literature concerning behavioural 
weight management trials will be extracted from the 2018 
USPSTF systematic review of interventions to prevent 
obesity- related morbidity and mortality in adults.14 Then, 
a search of the same databases used in the USPSTF review 
will be conducted to identify trials published since the 
search was completed for the USPSTF systematic review 
on 6th of June 2017. We will use the same search strat-
egies and terms as in the original report, but with phar-
macological interventions excluded and terms relating to 
adverse events removed.
Eligibility criteria
We will select studies according to the criteria outlined 
below.
Study designs
We will include research articles reporting RCTs and 
cluster- RCTs. To mirror the USPSTF review, only studies 
published in the English language will be included.
Participants
We will include studies of adults aged 18 years and over 
with overweight or obesity (body mass index >25 kg/m2) 
who are suitable for behavioural weight loss or behavioural 
weight loss maintenance interventions. Participants may 
have additional risk factors such as hypertension, dyslip-
idaemia, impaired glucose tolerance or impaired fasting 
glucose.
Studies will be excluded if the population: was not 
selected based on a weight- related measure; had secondary 
causes of obesity (such as steroid use); selected on the 
basis of having a chronic disease for which behavioural 
weight loss or behavioural weight loss maintenance is part 
of disease management; was of pregnant women; was of 
adults in institutions or if the intervention was targeted 
at parents in order to change the behaviour of children.
Interventions
Studies will be included if they were conducted in or 
recruited from primary care or a healthcare system, or 
could feasibly be implemented in or referred to from 
primary care. In the case of the latter, the interventions 
must be conducted as part of a healthcare setting or be 
available in the community at a national level, such as 
commercial weight loss interventions. We will include 
behavioural interventions that are focused on weight 
loss or weight loss maintenance. Interventions may be 
delivered either alone or as part of a multicomponent 
intervention on wider diet and nutrition, physical activity, 
sedentary behaviour or a combination of these. The 
intervention may include (but not limited to): assessment 
with feedback, advice, collaborative goal- setting, assis-
tance, exercise prescriptions (referral to exercise facility 
or programme), arranging further contacts or provider 
training.
The delivery of the intervention may be: face- to- face 
contact, telephone, print materials, or be computer- based 
or mobile phone- based technology (such as websites, 
apps or text messages). There is no restriction on who 
delivers the intervention.
Interventions of alternative and complementary treat-
ments (eg, mindfulness) will be excluded. All pharma-
cological and surgical interventions will be excluded, 
including in combination with behavioural interventions, 
unless the trial includes behavioural only and control 
arms.
Comparators
We will only include trials with a control group. The 
control group may receive no intervention (wait- list 
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Table 1 Definition of PROGRESS- Plus factors (adapted from Attwood et al)
PROGRESS- Plus 
factor Description Example measures
Place of residence Places, and perceptions of, where individuals live  ► Postcode
 ► Country, state, region, town or community
 ► Urban/rural
 ► Housing characteristics
 ► Distance to attend weight loss session
 ► Local food environment
 ► ‘Walkability’
Race/ethnicity Racial or ethnic group, or other classification of culture, 
language or nationality status
 ► Ethnicity classifications
 ► Country of origin
 ► Language
 ► Other classifications of culture




 ► Full time/part time
 ► Manual/non- manual
Gender/sex Gender is self- identified by individuals, incorporating 
ideas around socially constructed roles and behaviours
Sex refers to biological and physiological 
characteristics that define an individual as a man or 
woman
 ► Gender
 ► Sex (eg, male/female classifications)
Religion Religious affiliation or system of religious/spiritual 
beliefs or values
 ► Religious denomination
Education Extent and type of education or other formal training  ► Years in education
 ► Level of education attained (eg, for UK: 
GCSE, A- Levels, Undergraduate)
 ► Institutions attended (eg, for USA: high 
school/some college/college graduate/
university)
Socioeconomic status An individual’s position within a hierarchical social 
structure. Measures of socioeconomic status aim 
to capture access to resources, privilege, power or 
control
 ► Indices of Multiple Deprivation (UK only, 
Scottish Index of Multiple Deprivation)
 ► Social class
 ► Individual income
 ► Household income
 ► Receiving state welfare (eg, benefits/free 
prescriptions in the UK, Medicaid in the 
USA)
 ► Asset- based measures (eg, home or car 
ownership)
 ► Occupation (eg, occupation class)
Social capital Social capital aims to capture the obligations and 
benefits conferred on an individual by their society and 
social relationships. Can be viewed as a measure of 
interconnectedness between an individual and their 
social surroundings or group
 ► Marital/relationship status (eg, single, 
cohabiting)
 ► Household size
 ► Social support
 ► Social networks
 ► Civic participation/group membership
 ► Ability to use technology
Continued
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control or usual care) or minimal intervention (such as 
generic print or electronic materials).
Outcomes and prioritisation
Outcomes will occur at the three stages: uptake, adher-
ence/attendance and effectiveness.
Differential uptake will be considered at two stages. 
First, trial uptake will be calculated for each study using 
the formula:
 
Participants accepting invitation to trial
Participants invited to trial  
Second, uptake of the intervention arm. We are consid-
ering uptake of the intervention to be ‘attending’ at least 
one intervention session, the language of which is geared 
towards to those attending community group interven-
tions such as WW (formerly Weight Watchers). ‘Attend-
ance’ to an online- based intervention would be defined 
as logging into the online platform at least once. Hence, 
uptake of the intervention is defined as:
 
Participants attending at least one intervention session
Participants in trial arm  
The second outcome stage is adherence to the inter-
vention. We will consider adherence for each participant 
as either a binary variable (adhered vs not adhered) or 
using the below formula, depending on how adherence is 
defined in the included studies.
 
Number of sessions attended
Number of sessions prescribed  
The final outcome stage is effectiveness. This will be 
assessed at the 12- month follow- up using three measures: 
weight change in kilograms, weight loss of 5% or greater, 
and change in waist circumference.
Timing (eg, minimum follow-up)
As per the USPSTF review, we will only include studies that 
measure intervention effectiveness at 12 or 18 months. 
This is despite the different timings required for each of 
the outcomes. The uptake outcomes require data at two 
pre- intervention stages—invitation to trial and baseline—
as well as data on percentage of participants attending 
at least one session of an intervention. The adherence 
outcome will require data from baseline until the end of 
the intervention. Finally, intervention effectiveness will be 
assessed at 12 months or later from baseline.
Moderator variables
The moderator variables under consideration are the 
PROGRESS- Plus criteria. Possible measures of each 
of these criteria are shown in table 1, which has been 
adapted from a systematic review that explored equity in 
primary care- based physical activity interventions using 
PROGRESS- Plus.22
Setting
Eligible studies will have been conducted in primary care, 
referred from primary care or be applicable to primary 
care settings. As per the search performed in the USPSTF 
review, only studies conducted in countries that were 
members of the Organisation for Economic Co- operation 
and Development (as of 2017) are eligible for inclusion. 
These countries are: Australia, Austria, Belgium, Canada, 
Chile, Czech Republic, Denmark, Estonia, Finland, 
France, Germany, Greece, Hungary, Iceland, Israel, Italy, 
Japan, South Korea, Luxembourg, Mexico, the Nether-
lands, New Zealand, Norway, Poland, Portugal, Slovakia, 
Slovenia, Spain, Sweden, Switzerland, Turkey, the UK and 
the USA.
Information sources and search strategy
Electronic searches
It is anticipated that much of the PROGRESS- Plus data to 
be extracted will not be reported in the main write- up of 
each behavioural weight management intervention RCT. 
Hence, it is necessary to extract data from all publications 
associated with each individual RCT. To complete this, we 
will adopt a similar approach to literature searching as 
demonstrated by Orkin et al23
The search strategy will be completed in two phases. 
Phase 1 is identifying ‘parent’ RCTs. These studies will 
be identified in two ways. Initially, the behavioural weight 
loss and behavioural weight loss maintenance interven-
tions included in the USPSTF report will be extracted. 
Then, we will conduct an update of the literature search 
used in the USPSTF report to capture recent published 
trials using the same databases (Medline, CENTRAL and 
PsychInfo). Databases will be searched from June 2017 
(the last date of the USPSTF report) to February 2020. 
The search strategy includes the following concepts: (1) 
overweight and obesity AND (2) behavioural weight loss/
PROGRESS- Plus 
factor Description Example measures
Plus Any other factors over an individual’s life course that 
could lead to discrimination. Examples include age, 
disability and sexual orientation
 ► Self- reported age in years
 ► Measures of health status and/or quality of 
life (eg, EuroQoL, SF-36, EQ- 5D)
 ► Tests of physical function
 ► Physical or emotional/mental disability
 ► Self- reported sexual orientation (eg, 
heterosexual, homosexual, bisexual)
GCSE, General Certificate of Secondary Education; SF-36, 36- Item Short Form.
Table 1 Continued
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behavioural weight loss maintenance interventions. The 
Medline, CENTRAL and PsychInfo search strategies are 
outlined in online supplemental file B. In addition to the 
databases, reference lists of included published primary 
research and relevant systematic reviews and meta- 
analyses will be searched for possible further studies for 
inclusion.
Phase 2 is to ‘curate publication families’.23 This 
involves identifying publications of any type that relate to 
the parent RCT through electronic database searching. 
Authors and study identifiers (such as trial name) will 
be extracted from each parent RCT, which will then be 
searched for in the same electronic bibliographical data-
bases as phase 1. Each publication family will be consid-
ered as one study.
Study records
Data management and study selection
Search results will be imported into EndNote V.X7 bibli-
ographical software, where duplicates will be removed. 
The literature will then be loaded onto Covidence 
systematic review software (Veritas Health Innovation, 
Melbourne, Australia), and title and abstract screening 
conducted. Piloting of 500 articles will be conducted 
with minimum two investigators, where differences in 
interpretation of the inclusion criteria will be discussed 
between the investigators in order to achieve consistency 
in the review process. Once this has been completed, the 
remaining titles and abstracts will be screened for inclu-
sion by minimum two investigators independently. Full- 
text articles identified as being potentially relevant to 
the research questions will be accessed and screened by 
minimum two investigators. Any conflicts will be discussed 
and resolved by a third reviewer if agreement cannot be 
reached. For articles excluded at full- text stage, reasons 
for exclusion will be recorded.
Multiple articles reporting the same study will all be 
included and amalgamated to ensure all the best avail-
able data are used. A PRISMA flow chart will be reported 
to visualise the study selection.24
Data items
For studies highlighted as eligible for inclusion from the 
USPSTF report, and those that fulfil the inclusion criteria 
from our subsequent searches, we will extract data from 
the reports onto a data extraction form. To ensure that 
an appropriate breadth and depth of detail is captured, 
the data extraction form will be based on the Cochrane 
Public Health Group data extraction form,25 the Consoli-
dated Standards of Reporting Trials 2010 statement,26 the 
Template for Intervention Description and Replication 
checklist and the PROGRESS- Plus criteria.4 27
The following data will be extracted from the studies:
 ► General information (study authors, publication year, 
country and source of funding).
 ► Study information (study aim, design, recruitment 
location and method, randomisation, blinding and 
allocation concealment).
 ► Participant information (measures associated with the 
PROGRESS- Plus criteria as outlined in table 1).
 ► Intervention information (content, delivery method, 
group or individual- level, duration, setting, profession 
of person delivering intervention).
 ► Comparator information (control/usual care, 
content, delivery method, group or individual- level, 
duration, setting, profession of person delivering 
intervention).
 ► Uptake (number of participants invited to trial, 
number of participants accepting invite, number of 
participants randomised to intervention arm, number 
of participants attending >1 session), including impact 
of PROGRESS- Plus criteria on uptake.
 ► Adherence/attrition/attendance, including impact 
of PROGRESS- Plus criteria on these.
 ► Outcomes (outcomes studies, self- report or objective, 
follow- up duration, statistical analyses, intervention 
effect sizes), including impact of PROGRESS- Plus 
criteria on outcomes.
We will contact authors where data relating to the 
uptake, adherence and effectiveness outcomes have not 
been published. The corresponding author for each 
study will be contacted by email, and followed up after 
2 weeks if no response is received. One month from the 
initial email will be allowed for study authors to respond.
Risk of bias in individual studies
We will use Cochrane’s risk of bias tool for randomised 
trials (RoB 2) to assess risk of bias across all included 
studies.28 This ensures all included studies are assessed 
by the same criteria for the risk of bias. The tool covers 
six domains of possible bias: the randomisation process; 
allocation concealment; participant and trial personnel 
blinding; blinding of outcome assessment; incomplete 
outcome data and selective reporting. Each domain 
is given a ranking of ‘low risk’, ‘high risk’ or ‘unclear. 
This will be performed independently by at least two 
study authors. Where disagreements occur, these will 
be discussed between authors to reach consensus. A 
third reviewer will be consulted if agreement cannot be 
reached. Other possible sources of bias that do not fall 
within RoB 2’s six domains will be noted by reviewers, 
and commented on if appropriate in the final review. 
Reviewers will not be blinded to study information (such 
as study author, institution or journal). Results of the risk 
of bias assessments will be presented in a summary figure 
outlining a study’s overall risk of bias, as well as the risk of 
bias in each domain.
Data synthesis
Narrative synthesis and Harvest plots
We anticipate that there will be insufficient data to conduct 
a meta- analysis, therefore, the primary methods of data 
synthesis will be through narrative analysis and Harvest 
plots.29 Harvest plots were proposed by Ogilvie et al as a 
method for synthesising evidence of the differential effec-
tiveness of population- level public interventions,29 but 
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have been used in systematic reviews of various interven-
tion types since.30–35 Even where there is heterogeneity in 
measures used, Harvest plots allow for all available and 
relevant data to be used and presented.29 36 37 Several study 
features can be graphically demonstrated on a single plot, 
such as study quality, statistical significance and sample 
size. We will present a Harvest plot for each PROGRESS- 
Plus criteria and whether each trial found a negative, 
positive or no health inequality gradient; sample size of 
each study group; and whether the trial considered an 
intervention or interaction effect on the health inequality 
gradient.
Meta-analysis
Should there be sufficient data to conduct a meta- analysis, 
then the meta- analysis will consider two questions: are the 
PROGRESS- Plus criteria associated with the amount of weight 
loss achieved following behavioural weight management inter-
vention? and do the PROGRESS- Plus criteria moderate the 
effectiveness of behavioural weight management interventions?. 
ORs or risk ratios would be pooled for each question; the 
first question assesses if there is an association between 
the PROGRESS- Plus criteria and weight loss, the second 
question considers if there is an interaction. The data 
would be analysed using Stata V.16 (StataCorp 2019, 
College Station, Texas, USA), using a random- effects 
meta- analysis.
Statistical heterogeneity will be assessed using the I2 
statistic and its 95% CI. The I2 statistic will be interpreted 
against the following categorisations: 0%–40% might 
not be important; 30%–60% may represent moderate 
heterogeneity; 50%–90% may represent substantial 
heterogeneity and 75%–100% is likely considerable 
heterogeneity.38 The overlap in these categories exists as 
they are not intended as absolute threshold judgements, 
but as a guide to be used in conjunction with possible 
reasons explaining variability.38 Publication bias will be 
considered using a funnel plot.
Patient and public involvement
A patient and public involvement representative reviewed 
a lay summary of our proposed plan for the systematic 
review. Feedback was received on the review’s aims and 
definitions of the PROGRESS- Plus criteria. Once the 
review has been completed, feedback will be sought from 
the patient and public involvement representatives about 
the interpretation of findings and plans for an individual 
participant data meta- analysis.
ETHICS AND DISSEMINATION
Ethical approval is not required as only aggregate data are 
going to be acquired and will be used for the purpose for 
which they were originally collected for. Ethical approval 
for each trial to be included will have been sought by the 
original investigators. This systematic review will follow 
the PRISMA statement.24
Inequalities in overweight and obesity, and in health 
promotion interventions, are widely recognised. However, 
inequalities in behavioural weight loss interventions 
delivered or referred to from primary care (or similar) 
have not yet been considered in a systematic review. This 
review will identify data on where inequalities in weight 
loss interventions occur (ie, in which PROGRESS- Plus 
criteria), and at what stage (uptake, adherence or effec-
tiveness). We anticipate the completed systematic review 
will be published in a scientific journal, presented at 
conferences and contribute to the lead author’s PhD 
thesis. The review findings will contribute towards the 
consideration of intervention- generated inequalities by 
researchers, policymakers, and healthcare and public 
health practitioners.
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